The significant upregulation of HNRNPA2B1 in prostate cancer and strong correlation between HNRNPA2B1 and poor clinicopathological characteristics prompted us to further explore its role in tumor proliferation and invasion of PCa. This evidence concerns the gene HNRNPA2B1 and prostate carcinoma.